In vitro and in uiuo antibacterial activity of moxifloxacin, a novel quinolone antibacterial agent

Japanese Journal of Chemotherapy

Volumn 53, Issue , 2005, Pages 1-15

  Nishino, Takeshi ^a   Otsuki, Masako ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

animal model; antimicrobial activity; clinical isolate; moxifloxacin

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TOSUFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CULTURE MEDIUM; DRUG POTENCY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; LASER MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PH; TREATMENT OUTCOME;

EID: 30344484213     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1995.53.Supplement3_1     Document Type: Article

References (4)

1. Dalhoff A, Petersen U, Endermann R : In vitro activity of BAY 12-8039, a new 8-methoxyquinolone. Chemother 42 : 410-425,1996
2. Woodcock J M, Andrews J M, Boswell F J, et. al. : In vitro activity of BAY 12-8039, a new fluoroquinolonr. w 41 : 101~106,1997
3. Bauernfeind A : Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother 40 : 639~651,1997
4. Hiraga S, Niki H, Ogura T, et. al. : Chromosome partitioning in Escherichia coli : Novel mutants producing anucleate cells. J Bacteriol 171 : 1496~1505,1989